Anna Lembke, MD
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center
Bio:
Dr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine.
Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016). Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
"Drug Dealer, MD" combines case studies with public policy, cultural anthropology, and neuroscience, to explore the complex relationship between doctors and patients around prescribing controlled drugs. It has had an impact on policy makers and legislators across the nation. Dr. Lembke has testified before Congress and consulted with governors and senators from Kentucky to Missouri to Nevada. She was a featured guest on Fresh Air with Terry Gross, MSNBC with Chris Hayes, and numerous other media broadcasts.
Using her public platform and her faculty position at Stanford University School of Medicine, Dr. Lembke has developed multiple teaching programs on addiction and safe prescribing, as well as opioid tapering. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. Dr. Lembke continues to educate policymakers and the public about causes of and solutions for the problem of addiction.
Look for her new book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021).
Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016). Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
"Drug Dealer, MD" combines case studies with public policy, cultural anthropology, and neuroscience, to explore the complex relationship between doctors and patients around prescribing controlled drugs. It has had an impact on policy makers and legislators across the nation. Dr. Lembke has testified before Congress and consulted with governors and senators from Kentucky to Missouri to Nevada. She was a featured guest on Fresh Air with Terry Gross, MSNBC with Chris Hayes, and numerous other media broadcasts.
Using her public platform and her faculty position at Stanford University School of Medicine, Dr. Lembke has developed multiple teaching programs on addiction and safe prescribing, as well as opioid tapering. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. Dr. Lembke continues to educate policymakers and the public about causes of and solutions for the problem of addiction.
Look for her new book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021).
- 401 Quarry Road
- Stanford , CA 94304
- Phone: 650-498-9111
- 401 Quarry Road
- Stanford , CA 94304
- Phone: 650-498-9111
Practice Areas
- Addiction Disorders
- Anxiety
- Bipolar Disorder
- Depression
- Pain
- Psychoanalytic Treatment
- Psychotherapy
- Schizophrenia
- Urine Toxicology
Professional Education
- Medical Education: Stanford University School of Medicine (1995) CA
- Residency: Stanford University Adult Psychiatry Residency (2001) CA
- Residency: Stanford University Adult Psychiatry Residency (1998) CA
- Internship: Alameda County Highland Hospital Internal Medicine Residency (1996) CA
- Board Certification: American Board of Addiction Medicine, Addiction Medicine (2012)
- Board Certification: American Board of Psychiatry and Neurology, Psychiatry (2003)
Honors & Awards
- Chairman’s Clinical Innovation Award, Stanford University School of Medicine (2015)
- Distinguished Alpha Omega Alpha Visiting Professorship, University of Kansas School of Medicine (2018)
- Distinguished Alpha Omega Alpha Visiting Professorship, University of Nevada, Reno School of Medicine (2021)
- Distinguished Alumni Award, Evanston Township High School, Evanston, IL (2018)
- Distinguished Baldwin Lecturer, The Accreditation Council for Graduate Medical Education (ACGME) (2019)
- Distinguished Crowley Lecturer, Lucile Packard Children’s Hospital, Stanford University (2019)
- Distinguished Evelyn G. Keever Bioethics Day Lecturer, Eastern Virginia Medical School, Virginia (2019)
- Distinguished Flexner’s Dean Lecturer, Vanderbilt University School of Medicine (2018)
- Distinguished James Platt White Memorial Lecturer, Buffalo, New York OB/GYN Society (2019)
- Distinguished Marcel Malden Lecturer, Tacoma, Washington (2018)
- Distinguished Tector Lecturer, 69th Annual Course for Family Physicians, Montreal, Canada (2019)
- Distinguished University of Tampa Honors Symposium Lecturer, University of Tampa, Florida (2019)
- Distinguished Visiting Professorship, Johns Hopkins Bayview, Department of Internal Medicine (2017)
- Excellence in Academic Teaching, Stanford University School of Medicine (2014)
- Faculty Fellowship, Stanford University School of Medicine (2013)
- Fellowship Training Directors Award, American Society of Addiction Medicine (2020)
- Hazelden Betty Ford Foundation Humanitarian Kelly Clark Spirit Award, Hazelden Betty Ford Foundation, Portland, Oregon (2020)
- Irma Bland MD Certificate of Excellence in Teaching Residents, American Psychiatric Association (2020)
- Laughlin Fellowship, American College of Psychiatrists (2002)
- Outstanding Contributor to Community Life, Yale University (1989)
- Outstanding Research in Severe Mental Illness, American Psychiatric Association (2000)
- Outstanding Research in Severe Mental Illness, Janssen Scholar (1999)
- Outstanding Teacher in Structural Biology, Stanford University School of Medicine (1995)
- Summa cum laude in Humanities, Yale University (1989)
- Travel Scholarship, Alcohol Medical Scholars Program (2009)
- Travel Scholarship, Association of Medical Education, Research, Substance Abuse (2011)
- Travel Scholarship, Medical Education and Research Foundation (MERF) (2000)
- Yale-China Fellowship, Yale University (1989)
Administrative Appointments
- Chief, Addiction Medicine Dual Diagnosis Clinic, Department of Psychiatry, Stanford University (2010 - Present)
- Medical Director, Addiction Medicine, Department of Psychiatry, Stanford University (2015 - Present)
- Medical Director, Taube Youth Addiction Initiative (2020 - Present)
- Program Director, Addiction Medicine Fellowship, Department of Psychiatry, Stanford University (2013 - Present)
Publications
-
Depression in Individuals with Epilepsy.
Barry, J. J., Huynh, N., & Lembke, A. (2000). Depression in Individuals with Epilepsy. Current Treatment Options in Neurology, 2(6), 571–585. -
Impaired recognition of facial emotion in mania
Lembke, A., & Ketter, T. A. (2002). Impaired recognition of facial emotion in mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(2), 302–4. -
Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M., Das, B., Santosa, C. M., … Ketter, T. A. (2002). Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. BIPOLAR DISORDERS, 4(5), 328–34. -
Neural correlates of timbre change in harmonic sounds
Menon, V., Levitin, D. J., Smith, B. K., Lembke, A., Krasnow, B. D., Glazer, D., … McAdams, S. (2002). Neural correlates of timbre change in harmonic sounds. NEUROIMAGE, 17(4), 1742–1754.
-
Safety of antidepressants in the elderly.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., Wang, P., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert Opinion on Drug Safety, 2(4), 367–83.
-
A Friday in the life of an academic psychiatrist
Lembke, A. (2003). A Friday in the life of an academic psychiatrist. ACADEMIC PSYCHIATRY, 27(3), 214–15.
-
A prospective trial of modafinil as an adjunctive treatment of major depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(1), 87–90.
-
Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices
Barry, J. J., Lembke, A., & Bullock, K. D. (2004). Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices. CLINICAL EEG AND NEUROSCIENCE, 35(1), 4–13.
-
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Lembke, A., Miklowitz, D. J., Otto, M. W., Zhang, H., Wisniewski, S. R., Sachs, G. S., … Ketter, T. A. (2004). Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of Psychiatric Practice, 10(2), 81–87.
-
Why is this special issue on women's professional development in psychiatry necessary?
Lembke, A. (2004). Why is this special issue on women's professional development in psychiatry necessary? ACADEMIC PSYCHIATRY, 28(4), 275–77.
-
Update on augmentation of antidepressant response in resistant depression.
DeBattista, C., & Lembke, A. (2005). Update on augmentation of antidepressant response in resistant depression. Current Psychiatry Reports, 7(6), 435–40.
-
Depression and smoking cessation: does the evidence support psychiatric practice?
Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice? Neuropsychiatric Disease and Treatment, 3(4), 487–93.
-
Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization
Lembke, A., Bradley, K. A., Henderson, P., Moos, R., & Harris, A. H. S. (2011). Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization. JOURNAL OF GENERAL INTERNAL MEDICINE, 26(7), 777–82.
-
The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression
Lembke, A., Gomez, R., Tenakoon, L., Keller, J., Cohen, G., Williams, G. H., … Schatzberg, A. F. (2013). The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. PSYCHONEUROENDOCRINOLOGY, 38(1), 115–21.
-
Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders
Lembke, A. (2012). Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 38(6), 524–29.
-
Why Doctors Prescribe Opioids to Known Opioid Abusers
Lembke, A. (2012). Why Doctors Prescribe Opioids to Known Opioid Abusers. NEW ENGLAND JOURNAL OF MEDICINE, 367(17), 1580–81.
-
Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression.
Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Research, 211(2), 119–26.
-
From self-medication to intoxication: time for a paradigm shift.
Lembke, A. (2013). From self-medication to intoxication: time for a paradigm shift. Addiction , 108(4), 670–71.
-
Isolated meningeal vasculopathy associated with Clostridium septicum infection
Crowley, R. S., Lembke, A., & Horoupian, D. S. (1997). Isolated meningeal vasculopathy associated with Clostridium septicum infection. NEUROLOGY, 48(1), 265–267.
-
The status of evidence-based guidelines and algorithms in the treatment of depression
Debattista, C., Trivedi, M. H., Kern, J. K., & Lembke, A. (2002). The status of evidence-based guidelines and algorithms in the treatment of depression. PSYCHIATRIC ANNALS, 32(11), 658–663.
-
Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder
Miklowitz, D. J., Otto, M. W., Wisniewski, S. R., Araga, M., Frank, E., Reilly-Harrington, N. A., … Sachs, G. S. (2006). Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. PSYCHIATRIC SERVICES, 57(7), 959–65.
-
The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression
Che, A. M., Gomez, R. G., Keller, J., Lembke, A., Tennakoon, L., Cohen, G. H., & Schatzberg, A. F. (2012). The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression. PSYCHIATRY RESEARCH, 198(1), 34–38.
-
Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians.
Lembke, A. (2013). Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. Minnesota Medicine, 96(3), 36–37.
-
HPA axis genetic variation, cortisol and psychosis in major depression.
Schatzberg, A. F., Keller, J., Tennakoon, L., Lembke, A., Williams, G., Kraemer, F. B., … Murphy, G. M. (2014). HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry, 19(2), 220–27.
-
Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.
Yuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., … Parker, K. J. (2014). Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Journal of Psychiatric Research, 51, 30–36.
-
Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers
Harris, A. H. S., Ellerbe, L., Reeder, R. N., Bowe, T., Gordon, A. J., Hagedorn, H., … Trafton, J. A. (2013). Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers. PSYCHOLOGICAL SERVICES, 10(4), 410–19.
-
Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression
Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. PSYCHIATRY RESEARCH-NEUROIMAGING, 211(2), 119–26.
-
Recovery-oriented policy and care systems in the UK and USA.
Humphreys, K., & Lembke, A. (2014). Recovery-oriented policy and care systems in the UK and USA. Drug and Alcohol Review, 33(1), 13–18.
-
Clinical management of alcohol use disorders in the neurology clinic.
Lembke, A., & Stanford, M. (2014). Clinical management of alcohol use disorders in the neurology clinic. Handbook of Clinical Neurology, 125, 659–70.
-
Assessment of provider attitudes toward #naloxone on Twitter.
Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward #naloxone on Twitter. Substance Abuse, 37(1), 35–41.
-
A qualitative study of treatment-seeking heroin users in contemporary China.
Lembke, A., & Zhang, N. (2015). A qualitative study of treatment-seeking heroin users in contemporary China. Addiction Science & Clinical Practice, 10, 23-?
-
Weighing the Risks and Benefits of Chronic Opioid Therapy
Lembke, A., Humphreys, K., & Newmark, J. (2016). Weighing the Risks and Benefits of Chronic Opioid Therapy. AMERICAN FAMILY PHYSICIAN, 93(12), 982–90.
-
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence.
Leyro, T. M., Crew, E. E., Bryson, S. W., Lembke, A., Bailey, S. R., Prochaska, J. J., … David, S. P. (2016). Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open, 6(6).
-
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2016). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry.
-
Use of Opioid Agonist Therapy for Medicare Patients in 2013.
Lembke, A., & Chen, J. H. (2016). Use of Opioid Agonist Therapy for Medicare Patients in 2013. JAMA Psychiatry, 73(9), 990–92.
-
Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
Stein, M. D., Kanabar, M., Anderson, B. J., Lembke, A., & Bailey, G. L. (2016). Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Journal of Substance Abuse Treatment, 68, 57–61.
-
Extended treatment for cigarette smoking cessation: A randomized control trial.
Laude, J. R., Bailey, S. R., Crew, E., Varady, A., Lembke, A., McFall, D., … David, S. P. (2017). Extended treatment for cigarette smoking cessation: A randomized control trial. Addiction .
-
A Day in the Life of an Academic Psychiatrist.
Riba, M. B., Veith, R. C., Brodkey, A. C., Dimsdale, J. E., Zima, B. T., Stotland, N. L., … Arboleda-Flórez, J. (2003). A Day in the Life of an Academic Psychiatrist. Academic Psychiatry , 27(3), 187–224.
-
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., urphy, G. M., & Schatzberg, A. F. (2017). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. MOLECULAR PSYCHIATRY, 22(4), 527–36.
-
The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine
Lembke, A., & Humphreys, K. (2018). The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. ACADEMIC PSYCHIATRY, 42(2), 269–72.
-
Our Other Prescription Drug Problem
Lembke, A., Papac, J., & Humphreys, K. (2018). Our Other Prescription Drug Problem. NEW ENGLAND JOURNAL OF MEDICINE, 378(8), 693–95.
-
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Harrison, T. K., Kornfeld, H., Aggarwal, A. K., & Lembke, A. (2018). Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Anesthesiology Clinics, 36(3), 345–59.
-
Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum
Raber, I., Ball, A., Papac, J., Aggarwal, A., Sussman, R., Basaviah, P., … Lembke, A. (2018). Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum. Academic Psychiatry , 664–67.
-
Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
Raheemullah, A., & Lembke, A. (2019). Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. JAMA Internal Medicine.
-
Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period.
Lembke, A., Ottestad, E., & Schmiesing, C. (2019). Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. Pain Medicine (Malden, Mass.), 20(3), 425–28.
-
Distribution of Opioids by Different Types of Medicare Prescribers.
Chen, J. H., Humphreys, K., Shah, N. H., & Lembke, A. (2016). Distribution of Opioids by Different Types of Medicare Prescribers. JAMA Internal Medicine, 176(2), 259–61.
-
Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum.
Raber, I., Ball, A., Papac, J., Aggarwal, A., Sussman, R., Basaviah, P., … Lembke, A. (2018). Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 42(5), 664–67.
-
Tapering Patients Off of Benzodiazepines.
Ogbonna, C. I., & Lembke, A. (2017). Tapering Patients Off of Benzodiazepines. American Family Physician, 96(9), 606–10.
-
A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research.
Lembke, A., & Humphreys, K. (2016). A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Tobacco Control, 25(3), 261–62.
-
Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
Lembke, A., Ottestad, E., & Schmiesing, C. (2019). Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. PAIN MEDICINE, 20(3), 425–28.
-
Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Chou, R., Ballantyne, J., & Lembke, A. (2019). Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine. Annals of Internal Medicine.
-
Patterns of Opioid and Benzodiazepine Use in Opioid-Naive Patients with Newly Diagnosed Low Back and Lower Extremity Pain.
Azad, T. D., Zhang, Y., Stienen, M. N., Vail, D., Bentley, J. P., Ho, A. L., … Ratliff, J. K. (2019). Patterns of Opioid and Benzodiazepine Use in Opioid-Naive Patients with Newly Diagnosed Low Back and Lower Extremity Pain. Journal of General Internal Medicine.
-
Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine.
Raheemullah, A., & Lembke, A. (2019). Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. American Journal of Therapeutics.
-
Tapering Long-Term Opioid Therapy.
Lembke, A. (2020). Tapering Long-Term Opioid Therapy. American Family Physician, 101(1), 49–52.
-
Tapering Long-Term Opioid Therapy
Lembke, A. (2020). Tapering Long-Term Opioid Therapy. AMERICAN FAMILY PHYSICIAN, 101(1), 49–52.
-
Substance Use Among Older Adults: Ethical Issues.
Ogbonna, C. I., & Lembke, A. (2019). Substance Use Among Older Adults: Ethical Issues. Focus (American Psychiatric Publishing), 17(2), 143–47.
-
Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence.
Chou, R., Ballantyne, J., & Lembke, A. (2020). Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence. Annals of Internal Medicine, 172(4), 294.
-
Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence
Chou, R., Ballantyne, J., & Lembke, A. (2020). Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence. ANNALS OF INTERNAL MEDICINE, 172(4), 294.
-
Online mutual-help intervention for reducing heavy alcohol use.
Haug, N. A., Morimoto, E. E., & Lembke, A. (2020). Online mutual-help intervention for reducing heavy alcohol use. Journal of Addictive Diseases, 1–9.
-
Exercise and Addiction
Lembke, A., & Raheemullah, A. (2019). Exercise and Addiction. LIFESTYLE PSYCHIATRY, 127–39.
-
Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020).
Lembke, A. (2020). Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020). Journal of Studies on Alcohol and Drugs, 81(5), 564–65.
-
Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop
Lembke, A. (2016). Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Johns Hopkins University Press.
-
Dopamine Nation: Finding Balance in the Age of Indulgence
Lembke, A. (2021). Dopamine Nation: Finding Balance in the Age of Indulgence. Dutton Penguin Random House.
-
Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-A Commentary on Bonn et al. (2020)
Lembke, A. (2020). Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-A Commentary on Bonn et al. (2020). JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 81(5), 564–65.
-
Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report.
Deng, H., Benhamou, O.-M., & Lembke, A. (2021). Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report. Journal of Addictive Diseases, 1–6.